[Congressional Record Volume 154, Number 23 (Tuesday, February 12, 2008)]
[Extensions of Remarks]
[Page E160]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




 HONORING TIAN-LI YUE FOR RECEIVING THE 20TH ANNUAL PhRMA DISCOVERERS' 
                                 AWARD

                                 ______
                                 

                            HON. JOE SESTAK

                          of pennsylvania-----

                    in the house of representatives

                       Tuesday, February 12, 2008

  Mr. SESTAK. Madam Speaker, each year, the Pharmaceutical Research and 
Manufacturers of America (PhRMA) presents awards to researchers who 
have made incredible contributions to the development of a 
revolutionary medicine that helps patients live longer, healthier 
lives.
  Today, Tian-Li Yue received the 20th Annual PhRMA Discoverers Award 
from PhRMA. The Discoverers Award is PhRMA's highest honor and is 
presented to the biopharmaceutical scientists whose research and 
development of medicines have greatly benefited mankind, and whose 
dedication and interest in improving the quality of life of patients 
exemplifies the best in the research.
  This year's award has justly been presented to a cutting-edge 
researcher, and my constituent, Tian-Li Yue, who works for 
GlaxoSmithKline located in my home state of Pennsylvania.
  Therefore, on behalf of the U.S. Congress I would like to recognize 
Tian-Li Yue, Ph.D. for developing Coreg(r), which is used as a 
treatment for congestive heart failure.
  His unwavering dedication and life's work to improve the health and 
well being of mankind are to be commended. Patients suffering from 
heart failure and hypertension are forever in his debt.

                          ____________________